---
title: "BTIG Keeps Their Hold Rating on Globus Medical (GMED)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292616246.md"
description: "BTIG analyst Ryan Zimmerman maintained a Hold rating on Globus Medical (GMED) in a July 10 report, with shares closing at $78.11. While Stifel Nicolaus also issued a Hold, RBC Capital recently kept a Buy rating on the stock. The report highlights Zimmerman's track record as a 3-star analyst covering the healthcare sector."
datetime: "2026-07-14T11:26:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292616246.md)
  - [en](https://longbridge.com/en/news/292616246.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292616246.md)
generator: "portal-rs"
---

# BTIG Keeps Their Hold Rating on Globus Medical (GMED)

In a report released on July 10, Ryan Zimmerman from BTIG maintained a Hold rating on Globus Medical. The company’s shares closed yesterday at $78.11.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

According to TipRanks, Zimmerman is a 3-star analyst with an average return of 2.8% and a 44.53% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Glaukos, Intuitive Surgical, and Medtronic.

In addition to BTIG, Globus Medical also received a Hold from Stifel Nicolaus’s Thomas Stephan in a report issued on July 8. However, yesterday, RBC Capital maintained a Buy rating on Globus Medical (NYSE: GMED).

### Related Stocks

- [GMED.US](https://longbridge.com/en/quote/GMED.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [GKOS.US](https://longbridge.com/en/quote/GKOS.US.md)
- [ISRG.US](https://longbridge.com/en/quote/ISRG.US.md)
- [MDT.US](https://longbridge.com/en/quote/MDT.US.md)
- [SF.US](https://longbridge.com/en/quote/SF.US.md)
- [RY.US](https://longbridge.com/en/quote/RY.US.md)
- [SF-C.US](https://longbridge.com/en/quote/SF-C.US.md)
- [SFB.US](https://longbridge.com/en/quote/SFB.US.md)
- [SF-B.US](https://longbridge.com/en/quote/SF-B.US.md)
- [SF-D.US](https://longbridge.com/en/quote/SF-D.US.md)

## Related News & Research

- [Is Globus Medical (GMED) Cheap After Its Earnings Beat And Higher EPS Outlook?](https://longbridge.com/en/news/295317313.md)
- [BREAKINGVIEWS-India’s risks overdose on medical inflation fix](https://longbridge.com/en/news/297986133.md)
- [KKR buys stake in Malaysia's Avisena in healthcare push](https://longbridge.com/en/news/297986796.md)
- [How Investors May Respond To Evercore (EVR) Hiring Senior EMEA Healthcare Banker John Pissanos](https://longbridge.com/en/news/298090119.md)
- [TPG’s Asia OneHealthcare said to confidentially file for US$2.5 billion IPO](https://longbridge.com/en/news/297874967.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**